The U.S. Department of Justice recently announced that the federal government had secured $1.34 billion in settlements and judgments in federal fraud and abuse cases in FY 2008, with almost 78% were associated with False Claims Act whistleblower suits. Health care fraud accounted for the bulk of the settlements and judgments, totaling $1.12 billion. The largest recoveries were associated with pharmaceutical companies, including cases involving "off-label" marketing, kickbacks, marketing drug “spreads,” and knowingly failing to report a company’s true "best price" for a drug to reduce Medicaid rebates.